Allianz Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-119,121
Closed -$1.49M 2805
2019
Q1
$1.49M Sell
119,121
-7,119
-6% -$95.1K ﹤0.01% 1951
2018
Q4
$1.43M Sell
126,240
-154,732
-55% -$2.43M ﹤0.01% 1889
2018
Q3
$5.26M Sell
280,972
-10,209
-4% -$235K ﹤0.01% 1539
2018
Q2
$7.53M Sell
291,181
-17,714
-6% -$460K 0.01% 1365
2018
Q1
$6.92M Sell
308,895
-6,752
-2% -$165K 0.01% 1414
2017
Q4
$7.9M Buy
315,647
+180,183
+133% +$4.41M 0.01% 1422
2017
Q3
$3.28M Sell
135,464
-19,413
-13% -$456K ﹤0.01% 1823
2017
Q2
$3.13M Buy
154,877
+4,046
+3% +$84.3K ﹤0.01% 1820
2017
Q1
$4.06M Sell
150,831
-11,856
-7% -$242K ﹤0.01% 1715
2016
Q4
$3.09M Sell
162,687
-100,474
-38% -$1.92M ﹤0.01% 1807
2016
Q3
$5.14M Buy
263,161
+6,069
+2% +$103K 0.01% 1604
2016
Q2
$3.85M Buy
257,092
+108,074
+73% +$1.36M ﹤0.01% 1630
2016
Q1
$1.37M Sell
149,018
-5,768
-4% -$69.9K ﹤0.01% 1963
2015
Q4
$2.98M Buy
154,786
+86,410
+126% +$1.5M ﹤0.01% 1546
2015
Q3
$1.02M Buy
+68,376
New +$1.6M ﹤0.01% 1826

Other funds holding FLXN

Allianz Asset Management's FLXN Position: Q2 2019 in Review

Allianz Asset Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 119,121 shares — an estimated $1.49M sold.

Allianz Asset Management first reported a position in FLXN in Q3 2015 and held it in 15 quarters. The position peaked at $7.9M in Q4 2017. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.

  • Allianz Asset Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Allianz Asset Management sold 119,121 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $1.49M.
  • Allianz Asset Management first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 15 quarters.
  • Allianz Asset Management's Flexion Therapeutics, Inc. position peaked at $7.9M in Q4 2017.
  • 129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.

Based on Allianz Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.